NCT02845908View on ClinicalTrials.gov

POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2020

Conditions
Malignant Neoplasm of Stomach Stage IV
Interventions
DRUG

POF

Paclitaxel plus Oxaliplatin plus Leucovorin plus 5-FU

DRUG

FOLFOX

Oxaliplatin plus Leucovorin plus 5-FU

DRUG

FOLFOX plus PAC(ip)

FOLFOX plus intraperitoneally PAC

Trial Locations (1)

350014

Rongbo Lin, Fuzhou

All Listed Sponsors
lead

Fujian Cancer Hospital

OTHER_GOV

NCT02845908 - POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC | Biotech Hunter | Biotech Hunter